• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of New Drug Applications (NDAs) and Biologics License Applications (BLAs) submitted

Dictionary: Marketing Applications (New Drug Applications (NDAs) and Biologics License Applications (BLAs)) are applications to legally market a product in the U.S. for a specific use; these applications have legislatively mandated timelines for review.

Information is current as of March 31, 2014.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A7
Aug 2012N/A11
Sep 2012N/A15

FY 2012 3 month Total: 33

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Number of New Drug Applications (NDAs) and Biologics License Applications (BLAs) approved

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A7
Aug 2012N/A8
Sep 2012N/A7

FY 2012 3 month Total: 22

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Number of New Drug Applications (NDAs) and Biologics License Applications (BLAs) approved within the first cycle in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A6
Aug 2012N/A7
Sep 2012N/A6

FY 2012 3 month Total: 19

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.